$546 Million is the total value of SECTOR GAMMA AS's 33 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 27.6% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
PFE | Buy | PFIZER INC | $49,482,000 | +126.6% | 1,365,763 | +130.2% | 9.06% | +118.1% |
GILD | Sell | GILEAD SCIENCES INC | $43,860,000 | -10.2% | 678,633 | -19.0% | 8.03% | -13.5% |
MRK | Sell | MERCK & CO. INC | $39,021,000 | -17.5% | 506,176 | -12.5% | 7.15% | -20.6% |
INCY | Sell | INCYTE CORP | $27,717,000 | -9.4% | 341,051 | -3.0% | 5.08% | -12.8% |
MDT | Sell | MEDTRONIC PLC | $27,090,000 | -2.6% | 229,323 | -3.5% | 4.96% | -6.3% |
BDX | Sell | BECTON DICKINSON & CO | $24,750,000 | -18.8% | 101,787 | -16.5% | 4.53% | -21.9% |
BRKR | Buy | BRUKER CORP | $24,283,000 | +37.0% | 377,767 | +15.4% | 4.45% | +31.8% |
BMY | Buy | BRISTOL-MYERS SQUIBB CO | $23,425,000 | +4.5% | 371,062 | +2.7% | 4.29% | +0.6% |
CNC | Buy | CENTENE CORP DEL | $22,270,000 | +91.2% | 348,451 | +79.6% | 4.08% | +84.1% |
IONS | Buy | IONIS PHARMACEUTICALS INC | $20,419,000 | +12.5% | 454,150 | +41.5% | 3.74% | +8.3% |
ANTM | Buy | ANTHEM INC | $20,378,000 | +34.0% | 56,771 | +19.9% | 3.73% | +29.0% |
CAH | Buy | CARDINAL HEALTH INC | $19,711,000 | +26.5% | 324,464 | +11.6% | 3.61% | +21.8% |
NUVA | Buy | NUVASIVE INC | $18,308,000 | +27.3% | 279,259 | +9.4% | 3.35% | +22.5% |
CVS | Buy | CVS HEALTH CORP | $18,015,000 | +11.9% | 239,463 | +1.5% | 3.30% | +7.6% |
BAX | New | BAXTER INTL INC | $17,454,000 | – | 206,951 | +100.0% | 3.20% | – |
PKI | Sell | PERKINELMER INC | $15,070,000 | -27.0% | 117,467 | -18.4% | 2.76% | -29.8% |
BSX | Sell | BOSTON SCIENTIFIC CORP | $14,746,000 | -40.6% | 381,536 | -44.7% | 2.70% | -42.8% |
BIIB | Sell | BIOGEN INC | $13,780,000 | -14.2% | 49,260 | -24.9% | 2.52% | -17.4% |
ELAN | Buy | ELANCO ANIMAL HEALTH INC | $12,368,000 | +9.5% | 419,979 | +14.0% | 2.26% | +5.4% |
LH | Sell | LABORATORY CORP AMER HLDGS | $11,665,000 | -20.5% | 45,741 | -36.5% | 2.14% | -23.5% |
BIO | Sell | BIO RAD LABS INCcl a | $11,170,000 | -10.5% | 19,557 | -8.7% | 2.05% | -13.9% |
LIVN | Sell | LIVANOVA PLC | $10,432,000 | -21.7% | 141,483 | -29.7% | 1.91% | -24.6% |
ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $8,442,000 | +119.3% | 59,789 | +101.9% | 1.55% | +111.2% |
PRGO | Buy | PERRIGO CO PLC | $8,291,000 | +10.4% | 204,878 | +22.0% | 1.52% | +6.3% |
ALXN | Sell | ALEXION PHARMACEUTICALS INC | $7,746,000 | -66.5% | 50,657 | -65.7% | 1.42% | -67.7% |
BMRN | New | BIOMARIN PHARMACEUTICAL INC | $6,925,000 | – | 91,714 | +100.0% | 1.27% | – |
BNTX | New | BIONTECH SEsponsored ads | $5,896,000 | – | 54,000 | +100.0% | 1.08% | – |
HCA | Sell | HCA HEALTHCARE INC | $5,592,000 | -47.0% | 29,690 | -53.8% | 1.02% | -49.1% |
RIGL | Sell | RIGEL PHARMACEUTICALS INC | $5,234,000 | -6.5% | 1,530,490 | -4.3% | 0.96% | -10.0% |
JNJ | Sell | JOHNSON & JOHNSON | $4,931,000 | -10.5% | 30,000 | -14.3% | 0.90% | -13.8% |
UHS | New | UNIVERSAL HLTH SVCS INCcl b | $2,934,000 | – | 21,994 | +100.0% | 0.54% | – |
REGN | New | REGENERON PHARMACEUTICALS | $2,307,000 | – | 4,876 | +100.0% | 0.42% | – |
CVAC | New | CUREVAC N V | $2,287,000 | – | 25,000 | +100.0% | 0.42% | – |
NVAX | Exit | NOVAVAX INC | $0 | – | -11,500 | -100.0% | -0.24% | – |
ABT | Exit | ABBOTT LABS | $0 | – | -152,640 | -100.0% | -3.18% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-10
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
PERKINELMER INC | 33 | Q2 2021 | 6.3% |
BIOGEN INC | 30 | Q3 2023 | 7.6% |
ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-05 |
13F-HR | 2023-11-06 |
13F-HR | 2023-08-09 |
13F-HR | 2023-05-12 |
13F-HR/A | 2023-02-08 |
13F-HR | 2023-02-07 |
13F-HR | 2022-11-09 |
13F-HR | 2022-08-05 |
13F-HR | 2022-05-06 |
13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.